Insider Shareholders with Direct Ownership of Atea Pharmaceuticals, Inc. (AVIR)
This section provides a comprehensive overview of the insiders with direct ownership of Atea Pharmaceuticals, Inc. (AVIR). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Atea Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Chung K. Chu
> 10% Shareholder |
176,862 | 0 | 1,176,862 $3.51 Million | 1 |
Nov 03, 2020
Added 13.06%
|
| 232,238 | 31,945 | 717,307 $2.14 Million | 5 |
Jan 31, 2025
Reduced 2.2%
|
|
| 834,422 | 426,272 | 476,897 $1.42 Million | 7 |
Jan 16, 2025
Reduced 2.05%
|
|
|
Jean Pierre Sommadossi
President, CEO, and Chairman |
446,451 | 145,511 | 300,940 $896,801 | 4 |
Jan 31, 2025
Reduced 22.74%
|
| 33,150 | 0 | 83,150 $247,787 | 1 |
Jun 16, 2024
Added 28.5%
|
|
|
Janet Mj Hammond
Chief Development Officer |
104,850 | 28,163 | 81,388 $242,536 | 4 |
Jan 31, 2025
Reduced 14.8%
|
| 33,150 | 17,544 | 65,606 $195,505 | 2 |
Jun 20, 2024
Reduced 21.1%
|
|
|
Maria Arantxa Horga
Chief Medical Officer |
92,817 | 31,941 | 60,876 $181,410 | 4 |
Jan 31, 2025
Reduced 20.89%
|
| 45,150 | 0 | 56,445 $168,206 | 2 |
Jun 16, 2024
Added 37.0%
|
|
|
John Vavricka
Chief Commercial Officer |
75,417 | 23,336 | 52,081 $155,201 | 4 |
Jan 31, 2025
Reduced 18.11%
|
|
Wayne Foster
EVP, Chief Accounting Officer |
74,667 | 24,539 | 50,128 $149,381 | 4 |
Jan 31, 2025
Reduced 19.4%
|
| 33,150 | 0 | 33,150 $98,787 | 1 |
Jun 16, 2024
Added 50.0%
|
|
| 33,150 | 0 | 33,150 $98,787 | 1 |
Jun 16, 2024
Added 50.0%
|